Discovery of EP2 receptor opens path to pain relief without blocking inflammation
Scientists at the NYU Pain Research Center have identified which receptor in prostaglandins-the hormone-like substance targeted by common…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
GPR120 plays a key role in mediating the effects of n-3 fatty acids on mammary function
Background During lactation, the mammary gland undergoes significant structural and functional changes to produce milk, which is essential…
Molecular breast imaging increases overall invasive cancer detection in women with dense breasts
Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall…
The role of eating styles in diabetes control
New research reveals that patients who eat in response to food cues lose more weight on GLP-1 therapy,…
AlphaFold3 predicts bitter taste receptor structures with greater accuracy
Receptor proteins, expressed on the cell surface or within the cell, bind to different signaling molecules, known as…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Novel vitamin K analogs show promise for reversing neurodegenerative diseases
Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s disease are characterized by the progressive loss of neurons. The resulting…
Are GLP-1 drugs safe for women planning pregnancy?
New national data reveal a sharp rise in GLP-1 prescriptions for young women, but low contraception use leaves…
Why your playlist could be the key to reducing motion sickness
Scientists found that tuning into joyful or soft music can cut motion sickness by over half, offering a…
Multi-analyte test accurately identifies brain cancers using small cerebrospinal fluid
A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and…
Genetic variants mimicking IL-6 inhibition linked to lower cardiovascular risk
People with lower interleukin-6 activity have a reduced risk of cardiovascular diseases, a new LMU study reveals. Lowering…